Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
about
Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's diseaseSafety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.Individual Differences in Resting Corticospinal Excitability Are Correlated with Reaction Time and GABA Content in Motor Cortex.Transcranial brain stimulation: clinical applications and future directions.The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease.The EEG correlates of the TMS-induced EMG silent period in humans.Non-invasive brain stimulation for Parkinson's disease: Current concepts and outlook 2015.Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy.Treatment of Parkinson's disease by cortical stimulation.Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease.Exercise training reinstates cortico-cortical sensorimotor functional connectivity following striatal lesioning: development and application of a subregional-level analytic toolbox for perfusion autoradiographs of the rat brain.Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model studyInvestigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential TremorRetrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson's DiseaseMotor cortex stimulation in Parkinson's disease.Primary motor cortex of the parkinsonian monkey: altered encoding of active movementParkinson's disease: increased motor network activity in the absence of movementParkinson's disease rigidity: relation to brain connectivity and motor performance.Modulatory effect of subthalamic nucleus on the development of fatigue during exhausting exercise: an in vivo electrophysiological and microdialysis study in rats.Noninvasive brain stimulation for Parkinson's disease and dystonia.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersThe Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease.Primary motor cortex of the parkinsonian monkey: altered neuronal responses to muscle stretch.Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.Delayed and lasting effects of deep brain stimulation on locomotion in Parkinson's disease.Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network.Are the Symptoms of Parkinsonism Cortical in Origin?Male human motor cortex stimulus-response characteristics are not altered by aging.Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging.Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation.Premovement facilitation of corticospinal excitability in patients with Parkinson's disease.Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation.Where does chorea come from? cortical excitability findings challenge classic pathophysiological concepts.Combination of rTMS and treadmill training modulates corticomotor inhibition and improves walking in Parkinson disease: a randomized trial.
P2860
Q26782971-727FE0A8-8838-49D6-9A09-C6CD80075783Q26865819-AF001BEB-BDA5-4476-8460-92DEE8879343Q30151374-3F9A6F0C-133D-4B80-8DC3-CB62F0EDC244Q33855099-7ECF4330-ED9A-4813-8CA5-F40DB30A42C9Q34340821-BAA7F5C9-0976-48CC-A94F-F3F955659DEAQ34383595-6DC78976-AFAB-4B41-97C4-F1BA3FDFC076Q34413673-68215354-DDDC-4C2A-B512-44533B42ECEBQ34495843-5651C136-0000-4053-A83E-30D439A33A79Q34521827-D3FC9DC4-7AC8-4883-B63F-E014B0631A22Q34712560-8B8A7A3F-8C21-4BE3-9864-7FF11A47E5BCQ35015442-A93232FD-307D-4933-A866-1D56590489E1Q35024422-96774576-7D79-431D-AC90-DD8104BF5BDDQ35141832-A1DAADAA-DBD6-49E8-81A7-244F8FE7F6CCQ35485286-515A17B8-B824-4B95-92E7-BAA9811FFB9EQ36030067-16BFF5AE-64AE-415F-A7B2-07AB2CA1D42FQ36125228-23DDAF95-3893-4DD4-B6EA-A57F77515267Q36206620-1AF11937-4582-4DC4-A55C-373A47EEC018Q36418031-2CD38A2B-E924-4840-9909-5157600C8213Q36693900-2CB690B9-32CD-42A1-9972-C3BCE6A4F5BCQ36899657-922F2C06-E859-4C15-B0FB-0AF3FD0DAC62Q36903375-163E0C85-B44E-49D8-A160-8B2E226CDE49Q37081228-E3ED1140-EC70-4893-8E2E-56B245F2B4E9Q37131286-B36F0782-B12A-47F6-B203-D9EA5EB4775EQ37249765-A833EB18-2916-4CA5-BE5F-20D6CFE67068Q37270927-61E19B4F-DDFB-48E8-B0B4-857732E1C6F6Q37276021-A1B9F319-7ABA-400F-A0E4-076DA53F0B94Q37342353-9A261BA8-0969-42C6-A5A2-84F1897FAD7CQ37385099-7A4644ED-86DB-425E-8376-5B493B0FCBACQ37535989-B495C24F-72F4-40CE-8459-4CDD4CF44FC7Q37733153-00FFFAA5-397E-4AD2-BE4B-EEC72D73062AQ38207680-FD8CD134-B9DD-405D-9EAE-3184E1DA3C3BQ38245731-DAA95532-8D84-4851-B4F2-9CBD1E91FBD1Q39427212-060AC844-45C7-4E1F-9D9D-5519258EEAFDQ39818186-6B330E5D-8BC2-44F0-AFAF-486AC90C6B96Q39965038-EA846928-A0CE-4087-84CE-23B42082FD66Q41935713-727ECBB6-6000-4396-9E10-87EB5F6C4860Q43144133-098CA5B1-E586-4358-A395-4A133D4A6DE0Q48247812-0B4E2FFE-E7A0-444B-94FB-9643C096C704Q48397579-34493A8B-C6F0-4B0D-AF0E-663D72245643Q48444556-12E1AF25-B926-45BD-9247-CFF631C26639
P2860
Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@ast
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@en
type
label
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@ast
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@en
prefLabel
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@ast
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@en
P1476
Motor cortex dysfunction revea ...... ment and cortical stimulation.
@en
P2093
Jean-Pascal Lefaucheur
P304
P356
10.1016/J.CLINPH.2004.11.017
P577
2004-12-24T00:00:00Z